Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
primary studies published RCT
Details- 2017
- Lechtzin N
In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.
primary studies published RCT
Details- 2017
- McGarry ME
Physical Activity Counseling for Children With Cystic Fibrosis.
primary studies published RCT
Details- 2017
- Moola FJ
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.
primary studies published RCT
Details- 2017
- Muhlebach MS
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
primary studies published RCT
Details- 2017
- Nenna R
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.
primary studies published RCT
Details- 2017
- Ratjen F
Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis.
primary studies published RCT
Details- 2017
- Rowe SM
Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.
primary studies published RCT
Details- 2017
- Rowe SM
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.
primary studies published RCT
Details- 2017
- Taylor-Cousar JL
Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline.
primary studies published RCT
Details- 2016
- Adams C